Rob Abbott, CEO, ISPOR, highlights that the United States excels in areas like cancer screening and advanced medical ...

Pharma can embrace product iteration over one-time launches—and enhance agility and responsiveness through effective roadmaps ...

Novo Nordisk reduces Ozempic's price to $499/month for self-paying patients, enhancing access to essential diabetes treatment ...

Tonmya is the first new fibromyalgia therapy approved in over 15 years, targeting nonrestorative sleep to alleviate core ...

Vanda Pharmaceuticals won a legal battle as a federal court overturned the FDA's rejection of Hetlioz for jet lag disorder, ...

NIH's new strategy emphasizes transparency, prioritizes urgent health needs, and shifts focus to domestic research and ...

How a layered approach—tapping new avenues from earned media—can go a long way in boosting the brand engagement interplay ...

Expanded approval of Wegovy was based on results from the Phase III ESSENCE trial (NCT04822181), which demonstrated ...

What is MFN in pharma? President Trump’s executive order on drug pricing states that the United States should be treated as a ...

An examination of proactive preparedness and readiness review for future enrollment in the agency’s QMM program—now in the ...

As global director of healthcare and sciences at Google Cloud, Shweta Maniar is working with organizations to find ways to ...

Pharmaceutical Executive delivers strategic insights for pharma leaders, covering commercialization, market access, R&D, and leadership to drive success.